Mgr. Igor Popa, Ph.D.

Home About Personnel Mgr. Igor Popa, Ph.D.

Kontakt:

Email: igor.popa@upol.cz
Adresa: 17. listopadu 12, Olomouc
Telefon: (+420) 54 563 4497

Fax: (+420) 54 563 4357

Základní informace

Vybrané publikace

Oblast výzkumu

Syntéza organických látek
Syntéza komplexů vybraných přechodných kovů s bioaktivními ligandy
NMR spektroskopie přírodních, syntetických látek a komplexních sloučenin

Vzdělání a kvalifikace

1975 – 1980	Farmacie, Státní lékařská univerzita Moldavské republiky (Mgr.)
1980 – 1981	Zástupce vedoucího oddělení Hlavní lékařské správy Moldavské republiky
1981 – 1991	Vědecký pracovník Laboratoře bioanorganické chemie Ústavu chemie Akademie věd Moldavské republiky
1987 – 1990	Bioanorganická chemie, Ústav chemie Akademie věd Moldavské republiky (Ph.D.)
1990 – 1991	Studium na Fakultě zdokonalování lékařů Státní lékařské univerzity Moldavské republiky
1991 – 1993	Lékař klinické laboratorní diagnostiky Oddělení hemodialýzy Šesté Státní nemocnice (Kišiněv)
1993 – 1994	Vědecký pracovník Laboratoře analýzy a standardizace léků Národního farmaceutického ústavu Moldavské republiky
1994	Anorganická chemie, Státní univerzita Moldavské republiky, Chemická fakulta, Katedra anorganické chemie (CSc.)
1994 – 1995	Odborný asistent Katedry farmakologie Lékařské fakulty Přídněstrovské Státní univerzity (Tiraspol)
1995 – 1996	Odborný asistent Katedry farmaceutické chemie a farmakognózie Farmaceutické fakulty Nezávislé mezinárodní univerzity Moldavské republiky
1998 – 2000	Dočasný docent Katedry farmaceutické chemie a farmakognózie Farmaceutické fakulty Nezávislé mezinárodní univerzity Moldavské republiky
1998	Zahájeno habilitační řízení na funkci docenta, obor – farmaceutická chemie, Nezávislá mezinárodní univerzita Moldavské republiky, Farmaceutická fakulta, Katedra farmaceutické chemie a farmakognózie (nedokončeno z důvodu přestěhování do ČR)
2000 – 2008	Vědecký pracovník Laboratoře růstových regulátorů PřF UP v Olomouci
2009 – 2011	Vědecký pracovník Katedry anorganické chemie PřF UP v Olomouci
od 2010	Junior Researcher, Regionální centrum pokročilých technologií a materiálů PřF UP v Olomouci
od 2011	Odborný asistent Katedry anorganické chemie PřF UP v Olomouci

Publikační aktivita

Počet publikací (WoS): 50
Počet citací (WoS): 142
H-index: 6
Autor nebo spoluautor 7 patentů.

Vybrané publikace

E. Schutznerová, I. Popa, V. Kryštof, H. Koshino, Zdeněk Trávníček, P. Hradil, P. Cankař: Utilization of DmbNHNH2 in the synthesis of amino-substituted 4-((3,5-diamino-1H-pyrazol-4-yl)diazenyl)phenols, Tetrahedron 68 3996-4002 (2012).
M. Kubala, J. Vacek, I. Popa, M. Janovská, P, Kosina, J. Ulrichová, Z. Trávníček, V. Šimánek: The fluorescens properties and NMR analysis of protropine and allocryptopine, Journal of Luminiscence 131 1340-1345 (2011).
L. Dvořák, I. Popa, P. Štarha, Z. Trávníček: In Vitro Cytotoxic Active Platinum(II) Complexes Derived from Carboplatin and Involving Purine Derivatives, European Journal of Inorganic Chemistry 22 3441-3448 (2010).
Z. Trávníček, I. Popa, M. Čajan, R. Zbořil, V. Kryštof, J. Mikulík: The first iron(III) complexes with cyclin-dependent kinase inhibitors: magnetic, spectroscopic (IR, ES+ MS, NMR, ⁵⁷Fe Mössbauer), theoretical and biological activity studies, Journal of Inorganic Biochemistry 104(4), 405-417 (2010)
L. Spíchal, T. Werner, I. Popa, M. Riefler, T. Schmülling, M. Strnad: The purine derivative PI-55 blocks cytokinin action via receotor inhibition, Febs Journal 276(1), 244-253 (2009)
Z. Trávníček, J. Mikulík, M. Čajan, R. Zbořil, I. Popa: Novel iron complexes bearing N6 substituted adenosin derivatives: Synthesis, magnetic, Fe-57 Mossbauer, DFT, and in vitro cytotoxicity studies, Bioorganic and Medicinal Chemistry 16(18), 8719-8728 (2008)

Seznam publikací podle roku

2012

E. Schuetznerova, I. Popa, V. Krystof, H. Koshino, Z. Travnicek, P. Hradil, and P. Cankar, “Utilization of DmbNHNH(2) in the synthesis of amino-substituted 4-((3,5-diamino-1H-pyrazol-4-yl)diazenyl)phenols,” TETRAHEDRON, vol. 68, iss. 21, pp. 3996-4002, 2012.

2011

M. Kubala, J. Vacek, I. Popa, M. Janovska, P. Kosina, J. Ulrichova, Z. Travnicek, and V. Simanek, “The fluorescence properties and NMR analysis of protopine and allocryptopine,” JOURNAL OF LUMINESCENCE, vol. 131, iss. 7, pp. 1340-1345, 2011.
R. Novotna, I. Popa, and Z. Travnicek, “Zinc(II) chlorido complexes of protonated kinetin and its derivatives: Synthesis, properties and X-ray structure of [Zn(Hkinetin)Cl-3]center dot kinetin,” INORGANICA CHIMICA ACTA, vol. 365, iss. 1, pp. 113-118, 2011.
Z. Travnicek, R. Novotna, J. Marek, I. Popa, and M. Sipl, “Transformations of the natural cytokinin N6-isopentenyladenine in aqueous acidic media: structural aspects,” ORGANIC & BIOMOLECULAR CHEMISTRY, vol. 9, iss. 16, pp. 5703-5713, 2011.

2010

Z. Travnicek, P. Starha, I. Popa, R. Vrzal, and Z. Dvorak, “Roscovitine-based CDK inhibitors acting as N-donor ligands in the platinum(II) oxalato complexes: Preparation, characterization and in vitro cytotoxicity,” EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, vol. 45, iss. 10, pp. 4609-4614, 2010.
A. Klanicova, Z. Travnicek, J. Vanco, I. Popa, and Z. Sindelar, “Dinuclear copper(II) perchlorate complexes with 6-(benzylamino)purine derivatives: Synthesis, X-ray structure, magnetism and antiradical activity,” POLYHEDRON, vol. 29, iss. 13, pp. 2582-2589, 2010.
L. Dvorak, I. Popa, P. Starha, and Z. Travnicek, “In Vitro Cytotoxic-Active Platinum(II) Complexes Derived from Carboplatin and Involving Purine Derivatives,” EUROPEAN JOURNAL OF INORGANIC CHEMISTRY, iss. 22, pp. 3441-3448, 2010.
R. Novotna, Z. Travnicek, and I. Popa, “Synthesis and characterization of the first zinc(II) complexes involving kinetin and its derivatives: X-ray structures of 2-chloro-N6-furfuryl-9-isopropyladenine and [Zn(kinetin)(2)Cl-2]center dot CH3OH,” INORGANICA CHIMICA ACTA, vol. 363, iss. 10, pp. 2071-2079, 2010.
P. Starha, Z. Travnicek, and I. Popa, “Platinum(II) oxalato complexes with adenine-based carrier ligands showing significant in vitro antitumor activity,” JOURNAL OF INORGANIC BIOCHEMISTRY, vol. 104, iss. 6, pp. 639-647, 2010.
J. Nisler, M. Zatloukal, I. Popa, K. Dolezal, M. Strnad, and L. Spichal, “Cytokinin receptor antagonists derived from 6-benzylaminopurine,” PHYTOCHEMISTRY, vol. 71, iss. 7, pp. 823-830, 2010.
P. Starha, I. Popa, and Z. Travnicek, “Palladium(II) oxalato complexes involving N6-(benzyl)-9-isopropyladenine-based N-donor carrier ligands: Synthesis, general properties, H-1, C-13 and N-15\H-1\ NMR characterization and in vitro cytotoxicity,” INORGANICA CHIMICA ACTA, vol. 363, iss. 7, pp. 1469-1478, 2010.
Z. Travnicek, I. Popa, M. Cajan, R. Zboril, V. Krystof, and J. Mikulik, “The first iron(III) complexes with cyclin-dependent kinase inhibitors: Magnetic, spectroscopic (IR, ES+ MS, NMR, Fe-57 Mossbauer), theoretical, and biological activity studies,” JOURNAL OF INORGANIC BIOCHEMISTRY, vol. 104, iss. 4, pp. 405-417, 2010.
R. Novotna, Z. Travnicek, and I. Popa, “X-ray crystallographic and NMR study of the tautomerism in kinetin, kinetin riboside and their derivatives: A comparison between the solid state and solution,” JOURNAL OF MOLECULAR STRUCTURE, vol. 963, iss. 2-3, pp. 202-210, 2010.
Z. Travnicek, R. Pastorek, P. Starha, I. Popa, and V. Slovak, “Nickel(II) N-Benzyl-N-methyldithiocarbamato Complexes as Precursors for the Preparation of Graphite Oxidation Accelerators,” ZEITSCHRIFT FUR ANORGANISCHE UND ALLGEMEINE CHEMIE, vol. 636, iss. 8, pp. 1557-1564, 2010.

2009

M. Siller, P. Anzenbacher, E. Anzenbacherova, K. Dolezal, I. Popa, and M. Strnad, “Interactions of olomoucine II with main drug-metabolizing enzymes of human liver microsomal fraction,” TOXICOLOGY LETTERS, vol. 189, p. S108, 2009.
P. Starha, Z. Travnicek, and I. Popa, “Synthesis, characterization and in vitro cytotoxicity of the first palladium(II) oxalato complexes involving adenine-based ligands,” JOURNAL OF INORGANIC BIOCHEMISTRY, vol. 103, iss. 7, pp. 978-988, 2009.
L. Spichal, T. Werner, I. Popa, M. Riefler, T. Schmelling, and M. Strnad, “PI-55 is a purine-derived cytokinin antagonist that blocks cytokinin action via receptor inhibition,” FEBS JOURNAL, vol. 276, pp. 390-391, 2009.
M. Siller, P. Anzenbacher, E. Anzenbacherova, K. Dolezal, I. Popa, and M. Strnad, “Interactions of Olomoucine II with Human Liver Microsomal Cytochromes P450,” DRUG METABOLISM AND DISPOSITION, vol. 37, iss. 6, pp. 1198-1202, 2009.
L. Szucova, L. Spichal, K. Dolezal, M. Zatloukal, J. Greplova, P. Galuszka, V. Krystof, J. Voller, I. Popa, F. J. Massino, J. Jorgensen, and M. Strnad, “Synthesis, characterization and biological activity of ring-substituted 6-benzylamino-9-tetrahydropyran-2-yl and 9-tetrahydrofuran-2-ylpurine derivatives,” BIOORGANIC & MEDICINAL CHEMISTRY, vol. 17, iss. 5, pp. 1938-1947, 2009.
P. Starha, Z. Travnicek, R. Herchel, I. Popa, P. Suchy, and J. Vanco, “Dinuclear copper(II) complexes containing 6-(benzylamino)purines as bridging ligands: Synthesis, characterization, and in vitro and in vivo antioxidant activities,” JOURNAL OF INORGANIC BIOCHEMISTRY, vol. 103, iss. 3, pp. 432-440, 2009.
L. Spichal, T. Werner, I. Popa, M. Riefler, T. Schmuelling, and M. Strnad, “The purine derivative PI-55 blocks cytokinin action via receptor inhibition,” FEBS JOURNAL, vol. 276, iss. 1, pp. 244-253, 2009.

2008

Z. Travnicek, J. Mikulik, M. Cajan, R. Zboril, and I. Popa, “Novel iron complexes bearing N6-substituted adenosine derivatives: Synthesis, magnetic, (57)Fe Mossbauer, DFT, and in vitro cytotoxicity studies,” BIOORGANIC & MEDICINAL CHEMISTRY, vol. 16, iss. 18, pp. 8719-8728, 2008.
L. Szucova, Z. Travnicek, I. Popa, and J. Marek, “Preparation and cis-to-trans transformation study of square-planar [Pt(L(n))2Cl(2)] complexes bearing cytokinins derived from 6-benzylaminopurine (L(n)) by view of NMR spectroscopy and X-ray crystallography,” POLYHEDRON, vol. 27, iss. 12, pp. 2710-2720, 2008.

2007

Z. Travnicek, I. Popa, M. Cajan, R. Herchel, and J. Marek, “The first platinum(IV) complexes involving aromatic cytokinins or cyclin-dependent kinase inhibitors derived from 6-benzylaminopurine: X-ray structures of (BohH(2)(2+))[PtCl6] center dot H2O and (RosH(2)(2+))(2)[PtCl6]Cl-2 center dot 4H(2)O,” POLYHEDRON, vol. 26, iss. 18, pp. 5271-5282, 2007.
K. Dolezal, I. Popa, E. Hauserova, L. Spichal, K. Chakrabarty, O. Novak, V. Krystof, J. Voller, J. Holub, and M. Strnad, “Preparation, biological activity and endogenous occurrence of N-6-benzyladenosines,” BIOORGANIC & MEDICINAL CHEMISTRY, vol. 15, iss. 11, pp. 3737-3747, 2007.
Z. Travnicek, L. Szucova, and I. Popa, “Synthesis, characterization and assessment of the cytotoxic properties of cis and trans-[Pd(L)(2)Cl-2] complexes involving 6-benzylamino-9-isopropylpurine derivatives,” JOURNAL OF INORGANIC BIOCHEMISTRY, vol. 101, iss. 3, pp. 477-492, 2007.
Z. Travnicek and I. Popa, “2-chloro-6-[(4-hydroxy-3,5-dimethoxybenzyl)amino]-9-isopropylpurine,” ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, vol. 63, iss. Part 2, p. O728-O730, 2007.
Z. Travnicek and I. Popa, “2-chloro-6-[(2,6-dimethoxybenzyl)amino]9-isopropylpurine 0.125-hydrate,” ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, vol. 63, iss. Part 2, p. O629-O631, 2007.
J. Stranska, M. Sebela, P. Tarkowski, P. Rehulka, J. Chmelik, I. Popa, and P. Pec, “Inhibition of plant amine oxidases by a novel series of diamine derivatives,” BIOCHIMIE, vol. 89, iss. 1, pp. 135-144, 2007.
F. Sersen, D. Loos, J. Csollei, I. Popa, J. Vanco, and F. Gregan, “Antioxidative activity of potential antihypertensives with dual effect,” CHEMICKE LISTY, vol. 101, iss. 1, pp. 60-64, 2007.

2006

A. Klanicova, Z. Travnicek, I. Popa, M. Cajan, and K. Dolezal, “Synthesis, characterization and in vitro cytotoxicity of Co(II) complexes with N6-substituted adenine derivatives: X-ray structures of 6-(4-chlorobenzylamino)purin-di-ium diperchlorate dihydrate and [Co-6(mu-L-6)(4)Cl-8(DMSO)(10)] center dot 4DMSO,” POLYHEDRON, vol. 25, iss. 6, pp. 1421-1432, 2006.
Z. Travnicek, J. Marek, and I. Popa, “6-(2-Chloro-4-fluorobenzylamino)purine,” ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, vol. 62, iss. Part 4, p. O1536-O1538, 2006.
K. Dolezal, I. Popa, V. Krystof, L. Spichal, M. Fojtikova, J. Holub, R. Lenobel, T. Schmulling, and M. Strnad, “Preparation and biological activity of 6-benzylaminopurine derivatives in plants and human cancer cells,” BIOORGANIC & MEDICINAL CHEMISTRY, vol. 14, iss. 3, pp. 875-884, 2006.
L. Szucova, Z. Travnicek, M. Zatloukal, and I. Popa, “Novel platinum(II) and palladium(II) complexes with cyclin-dependent kinase inhibitors: Synthesis, characterization and antitumour activity,” BIOORGANIC & MEDICINAL CHEMISTRY, vol. 14, iss. 2, pp. 479-491, 2006.

2005

E. Hauserova, J. Swaczynova, K. Dolezal, R. Lenobel, I. Popa, M. Hajduch, D. Vydra, K. Fuksova, and M. Strnad, “Batch immunoextraction method for efficient purification of aromatic cytokinins,” JOURNAL OF CHROMATOGRAPHY A, vol. 1100, iss. 1, pp. 116-125, 2005.
Z. Travnicek, M. Sipl, and I. Popa, “Palladium(II) complexes containing cytokinins derived from 6-benzylaminopurine,” JOURNAL OF COORDINATION CHEMISTRY, vol. 58, iss. 16, pp. 1513-1521, 2005.
Z. Travnicek, A. Klanicova, I. Popa, and J. Rolcik, “Synthetic, spectral, magnetic and in vitro cytotoxic activity studies of cobalt(II) complexes with cytokinin derivatives: X-ray structure of 6-(3-methoxybenzylamino)purinium chloride monohydrate,” JOURNAL OF INORGANIC BIOCHEMISTRY, vol. 99, iss. 3, pp. 776-786, 2005.

2004

Z. Travnicek, I. Popa, and K. Dolezal, “6-(4-methoxybenzylamino)purin-3-ium chloride,” ACTA CRYSTALLOGRAPHICA SECTION C-CRYSTAL STRUCTURE COMMUNICATIONS, vol. 60, iss. Part 9, p. O662-O664, 2004.

2002

Z. Travnicek, M. Malon, I. Popa, K. Dolezal, and M. Strnad, “Preparation and cytotoxic activity of nickel(II) complexes with 6-benzylaminopurine derivatives,” TRANSITION METAL CHEMISTRY, vol. 27, iss. 8, pp. 918-923, 2002.

Kontakt:

Email: igor.popa@upol.cz
Adresa: 17. listopadu 12, Olomouc
Telefon: (+420) 54 563 4497

Fax: (+420) 54 563 4357

Základní informace

Vybrané publikace

Oblast výzkumu

Syntéza organických látek
Syntéza komplexů vybraných přechodných kovů s bioaktivními ligandy
NMR spektroskopie přírodních, syntetických látek a komplexních sloučenin

Vzdělání a kvalifikace

1975 – 1980	Farmacie, Státní lékařská univerzita Moldavské republiky (Mgr.)
1980 – 1981	Zástupce vedoucího oddělení Hlavní lékařské správy Moldavské republiky
1981 – 1991	Vědecký pracovník Laboratoře bioanorganické chemie Ústavu chemie Akademie věd Moldavské republiky
1987 – 1990	Bioanorganická chemie, Ústav chemie Akademie věd Moldavské republiky (Ph.D.)
1990 – 1991	Studium na Fakultě zdokonalování lékařů Státní lékařské univerzity Moldavské republiky
1991 – 1993	Lékař klinické laboratorní diagnostiky Oddělení hemodialýzy Šesté Státní nemocnice (Kišiněv)
1993 – 1994	Vědecký pracovník Laboratoře analýzy a standardizace léků Národního farmaceutického ústavu Moldavské republiky
1994	Anorganická chemie, Státní univerzita Moldavské republiky, Chemická fakulta, Katedra anorganické chemie (CSc.)
1994 – 1995	Odborný asistent Katedry farmakologie Lékařské fakulty Přídněstrovské Státní univerzity (Tiraspol)
1995 – 1996	Odborný asistent Katedry farmaceutické chemie a farmakognózie Farmaceutické fakulty Nezávislé mezinárodní univerzity Moldavské republiky
1998 – 2000	Dočasný docent Katedry farmaceutické chemie a farmakognózie Farmaceutické fakulty Nezávislé mezinárodní univerzity Moldavské republiky
1998	Zahájeno habilitační řízení na funkci docenta, obor – farmaceutická chemie, Nezávislá mezinárodní univerzita Moldavské republiky, Farmaceutická fakulta, Katedra farmaceutické chemie a farmakognózie (nedokončeno z důvodu přestěhování do ČR)
2000 – 2008	Vědecký pracovník Laboratoře růstových regulátorů PřF UP v Olomouci
2009 – 2011	Vědecký pracovník Katedry anorganické chemie PřF UP v Olomouci
od 2010	Junior Researcher, Regionální centrum pokročilých technologií a materiálů PřF UP v Olomouci
od 2011	Odborný asistent Katedry anorganické chemie PřF UP v Olomouci

Publikační aktivita

Počet publikací (WoS): 50
Počet citací (WoS): 142
H-index: 6
Autor nebo spoluautor 7 patentů.

Vybrané publikace

E. Schutznerová, I. Popa, V. Kryštof, H. Koshino, Zdeněk Trávníček, P. Hradil, P. Cankař: Utilization of DmbNHNH2 in the synthesis of amino-substituted 4-((3,5-diamino-1H-pyrazol-4-yl)diazenyl)phenols, Tetrahedron 68 3996-4002 (2012).
M. Kubala, J. Vacek, I. Popa, M. Janovská, P, Kosina, J. Ulrichová, Z. Trávníček, V. Šimánek: The fluorescens properties and NMR analysis of protropine and allocryptopine, Journal of Luminiscence 131 1340-1345 (2011).
L. Dvořák, I. Popa, P. Štarha, Z. Trávníček: In Vitro Cytotoxic Active Platinum(II) Complexes Derived from Carboplatin and Involving Purine Derivatives, European Journal of Inorganic Chemistry 22 3441-3448 (2010).
Z. Trávníček, I. Popa, M. Čajan, R. Zbořil, V. Kryštof, J. Mikulík: The first iron(III) complexes with cyclin-dependent kinase inhibitors: magnetic, spectroscopic (IR, ES+ MS, NMR, ⁵⁷Fe Mössbauer), theoretical and biological activity studies, Journal of Inorganic Biochemistry 104(4), 405-417 (2010)
L. Spíchal, T. Werner, I. Popa, M. Riefler, T. Schmülling, M. Strnad: The purine derivative PI-55 blocks cytokinin action via receotor inhibition, Febs Journal 276(1), 244-253 (2009)
Z. Trávníček, J. Mikulík, M. Čajan, R. Zbořil, I. Popa: Novel iron complexes bearing N6 substituted adenosin derivatives: Synthesis, magnetic, Fe-57 Mossbauer, DFT, and in vitro cytotoxicity studies, Bioorganic and Medicinal Chemistry 16(18), 8719-8728 (2008)

Seznam publikací podle roku

2012

E. Schuetznerova, I. Popa, V. Krystof, H. Koshino, Z. Travnicek, P. Hradil, and P. Cankar, “Utilization of DmbNHNH(2) in the synthesis of amino-substituted 4-((3,5-diamino-1H-pyrazol-4-yl)diazenyl)phenols,” TETRAHEDRON, vol. 68, iss. 21, pp. 3996-4002, 2012.

2011

M. Kubala, J. Vacek, I. Popa, M. Janovska, P. Kosina, J. Ulrichova, Z. Travnicek, and V. Simanek, “The fluorescence properties and NMR analysis of protopine and allocryptopine,” JOURNAL OF LUMINESCENCE, vol. 131, iss. 7, pp. 1340-1345, 2011.
R. Novotna, I. Popa, and Z. Travnicek, “Zinc(II) chlorido complexes of protonated kinetin and its derivatives: Synthesis, properties and X-ray structure of [Zn(Hkinetin)Cl-3]center dot kinetin,” INORGANICA CHIMICA ACTA, vol. 365, iss. 1, pp. 113-118, 2011.
Z. Travnicek, R. Novotna, J. Marek, I. Popa, and M. Sipl, “Transformations of the natural cytokinin N6-isopentenyladenine in aqueous acidic media: structural aspects,” ORGANIC & BIOMOLECULAR CHEMISTRY, vol. 9, iss. 16, pp. 5703-5713, 2011.

2010

Z. Travnicek, P. Starha, I. Popa, R. Vrzal, and Z. Dvorak, “Roscovitine-based CDK inhibitors acting as N-donor ligands in the platinum(II) oxalato complexes: Preparation, characterization and in vitro cytotoxicity,” EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, vol. 45, iss. 10, pp. 4609-4614, 2010.
A. Klanicova, Z. Travnicek, J. Vanco, I. Popa, and Z. Sindelar, “Dinuclear copper(II) perchlorate complexes with 6-(benzylamino)purine derivatives: Synthesis, X-ray structure, magnetism and antiradical activity,” POLYHEDRON, vol. 29, iss. 13, pp. 2582-2589, 2010.
L. Dvorak, I. Popa, P. Starha, and Z. Travnicek, “In Vitro Cytotoxic-Active Platinum(II) Complexes Derived from Carboplatin and Involving Purine Derivatives,” EUROPEAN JOURNAL OF INORGANIC CHEMISTRY, iss. 22, pp. 3441-3448, 2010.
R. Novotna, Z. Travnicek, and I. Popa, “Synthesis and characterization of the first zinc(II) complexes involving kinetin and its derivatives: X-ray structures of 2-chloro-N6-furfuryl-9-isopropyladenine and [Zn(kinetin)(2)Cl-2]center dot CH3OH,” INORGANICA CHIMICA ACTA, vol. 363, iss. 10, pp. 2071-2079, 2010.
P. Starha, Z. Travnicek, and I. Popa, “Platinum(II) oxalato complexes with adenine-based carrier ligands showing significant in vitro antitumor activity,” JOURNAL OF INORGANIC BIOCHEMISTRY, vol. 104, iss. 6, pp. 639-647, 2010.
J. Nisler, M. Zatloukal, I. Popa, K. Dolezal, M. Strnad, and L. Spichal, “Cytokinin receptor antagonists derived from 6-benzylaminopurine,” PHYTOCHEMISTRY, vol. 71, iss. 7, pp. 823-830, 2010.
P. Starha, I. Popa, and Z. Travnicek, “Palladium(II) oxalato complexes involving N6-(benzyl)-9-isopropyladenine-based N-donor carrier ligands: Synthesis, general properties, H-1, C-13 and N-15\H-1\ NMR characterization and in vitro cytotoxicity,” INORGANICA CHIMICA ACTA, vol. 363, iss. 7, pp. 1469-1478, 2010.
Z. Travnicek, I. Popa, M. Cajan, R. Zboril, V. Krystof, and J. Mikulik, “The first iron(III) complexes with cyclin-dependent kinase inhibitors: Magnetic, spectroscopic (IR, ES+ MS, NMR, Fe-57 Mossbauer), theoretical, and biological activity studies,” JOURNAL OF INORGANIC BIOCHEMISTRY, vol. 104, iss. 4, pp. 405-417, 2010.
R. Novotna, Z. Travnicek, and I. Popa, “X-ray crystallographic and NMR study of the tautomerism in kinetin, kinetin riboside and their derivatives: A comparison between the solid state and solution,” JOURNAL OF MOLECULAR STRUCTURE, vol. 963, iss. 2-3, pp. 202-210, 2010.
Z. Travnicek, R. Pastorek, P. Starha, I. Popa, and V. Slovak, “Nickel(II) N-Benzyl-N-methyldithiocarbamato Complexes as Precursors for the Preparation of Graphite Oxidation Accelerators,” ZEITSCHRIFT FUR ANORGANISCHE UND ALLGEMEINE CHEMIE, vol. 636, iss. 8, pp. 1557-1564, 2010.

2009

M. Siller, P. Anzenbacher, E. Anzenbacherova, K. Dolezal, I. Popa, and M. Strnad, “Interactions of olomoucine II with main drug-metabolizing enzymes of human liver microsomal fraction,” TOXICOLOGY LETTERS, vol. 189, p. S108, 2009.
P. Starha, Z. Travnicek, and I. Popa, “Synthesis, characterization and in vitro cytotoxicity of the first palladium(II) oxalato complexes involving adenine-based ligands,” JOURNAL OF INORGANIC BIOCHEMISTRY, vol. 103, iss. 7, pp. 978-988, 2009.
L. Spichal, T. Werner, I. Popa, M. Riefler, T. Schmelling, and M. Strnad, “PI-55 is a purine-derived cytokinin antagonist that blocks cytokinin action via receptor inhibition,” FEBS JOURNAL, vol. 276, pp. 390-391, 2009.
M. Siller, P. Anzenbacher, E. Anzenbacherova, K. Dolezal, I. Popa, and M. Strnad, “Interactions of Olomoucine II with Human Liver Microsomal Cytochromes P450,” DRUG METABOLISM AND DISPOSITION, vol. 37, iss. 6, pp. 1198-1202, 2009.
L. Szucova, L. Spichal, K. Dolezal, M. Zatloukal, J. Greplova, P. Galuszka, V. Krystof, J. Voller, I. Popa, F. J. Massino, J. Jorgensen, and M. Strnad, “Synthesis, characterization and biological activity of ring-substituted 6-benzylamino-9-tetrahydropyran-2-yl and 9-tetrahydrofuran-2-ylpurine derivatives,” BIOORGANIC & MEDICINAL CHEMISTRY, vol. 17, iss. 5, pp. 1938-1947, 2009.
P. Starha, Z. Travnicek, R. Herchel, I. Popa, P. Suchy, and J. Vanco, “Dinuclear copper(II) complexes containing 6-(benzylamino)purines as bridging ligands: Synthesis, characterization, and in vitro and in vivo antioxidant activities,” JOURNAL OF INORGANIC BIOCHEMISTRY, vol. 103, iss. 3, pp. 432-440, 2009.
L. Spichal, T. Werner, I. Popa, M. Riefler, T. Schmuelling, and M. Strnad, “The purine derivative PI-55 blocks cytokinin action via receptor inhibition,” FEBS JOURNAL, vol. 276, iss. 1, pp. 244-253, 2009.

2008

Z. Travnicek, J. Mikulik, M. Cajan, R. Zboril, and I. Popa, “Novel iron complexes bearing N6-substituted adenosine derivatives: Synthesis, magnetic, (57)Fe Mossbauer, DFT, and in vitro cytotoxicity studies,” BIOORGANIC & MEDICINAL CHEMISTRY, vol. 16, iss. 18, pp. 8719-8728, 2008.
L. Szucova, Z. Travnicek, I. Popa, and J. Marek, “Preparation and cis-to-trans transformation study of square-planar [Pt(L(n))2Cl(2)] complexes bearing cytokinins derived from 6-benzylaminopurine (L(n)) by view of NMR spectroscopy and X-ray crystallography,” POLYHEDRON, vol. 27, iss. 12, pp. 2710-2720, 2008.

2007

Z. Travnicek, I. Popa, M. Cajan, R. Herchel, and J. Marek, “The first platinum(IV) complexes involving aromatic cytokinins or cyclin-dependent kinase inhibitors derived from 6-benzylaminopurine: X-ray structures of (BohH(2)(2+))[PtCl6] center dot H2O and (RosH(2)(2+))(2)[PtCl6]Cl-2 center dot 4H(2)O,” POLYHEDRON, vol. 26, iss. 18, pp. 5271-5282, 2007.
K. Dolezal, I. Popa, E. Hauserova, L. Spichal, K. Chakrabarty, O. Novak, V. Krystof, J. Voller, J. Holub, and M. Strnad, “Preparation, biological activity and endogenous occurrence of N-6-benzyladenosines,” BIOORGANIC & MEDICINAL CHEMISTRY, vol. 15, iss. 11, pp. 3737-3747, 2007.
Z. Travnicek, L. Szucova, and I. Popa, “Synthesis, characterization and assessment of the cytotoxic properties of cis and trans-[Pd(L)(2)Cl-2] complexes involving 6-benzylamino-9-isopropylpurine derivatives,” JOURNAL OF INORGANIC BIOCHEMISTRY, vol. 101, iss. 3, pp. 477-492, 2007.
Z. Travnicek and I. Popa, “2-chloro-6-[(4-hydroxy-3,5-dimethoxybenzyl)amino]-9-isopropylpurine,” ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, vol. 63, iss. Part 2, p. O728-O730, 2007.
Z. Travnicek and I. Popa, “2-chloro-6-[(2,6-dimethoxybenzyl)amino]9-isopropylpurine 0.125-hydrate,” ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, vol. 63, iss. Part 2, p. O629-O631, 2007.
J. Stranska, M. Sebela, P. Tarkowski, P. Rehulka, J. Chmelik, I. Popa, and P. Pec, “Inhibition of plant amine oxidases by a novel series of diamine derivatives,” BIOCHIMIE, vol. 89, iss. 1, pp. 135-144, 2007.
F. Sersen, D. Loos, J. Csollei, I. Popa, J. Vanco, and F. Gregan, “Antioxidative activity of potential antihypertensives with dual effect,” CHEMICKE LISTY, vol. 101, iss. 1, pp. 60-64, 2007.

2006

A. Klanicova, Z. Travnicek, I. Popa, M. Cajan, and K. Dolezal, “Synthesis, characterization and in vitro cytotoxicity of Co(II) complexes with N6-substituted adenine derivatives: X-ray structures of 6-(4-chlorobenzylamino)purin-di-ium diperchlorate dihydrate and [Co-6(mu-L-6)(4)Cl-8(DMSO)(10)] center dot 4DMSO,” POLYHEDRON, vol. 25, iss. 6, pp. 1421-1432, 2006.
Z. Travnicek, J. Marek, and I. Popa, “6-(2-Chloro-4-fluorobenzylamino)purine,” ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, vol. 62, iss. Part 4, p. O1536-O1538, 2006.
K. Dolezal, I. Popa, V. Krystof, L. Spichal, M. Fojtikova, J. Holub, R. Lenobel, T. Schmulling, and M. Strnad, “Preparation and biological activity of 6-benzylaminopurine derivatives in plants and human cancer cells,” BIOORGANIC & MEDICINAL CHEMISTRY, vol. 14, iss. 3, pp. 875-884, 2006.
L. Szucova, Z. Travnicek, M. Zatloukal, and I. Popa, “Novel platinum(II) and palladium(II) complexes with cyclin-dependent kinase inhibitors: Synthesis, characterization and antitumour activity,” BIOORGANIC & MEDICINAL CHEMISTRY, vol. 14, iss. 2, pp. 479-491, 2006.

2005

E. Hauserova, J. Swaczynova, K. Dolezal, R. Lenobel, I. Popa, M. Hajduch, D. Vydra, K. Fuksova, and M. Strnad, “Batch immunoextraction method for efficient purification of aromatic cytokinins,” JOURNAL OF CHROMATOGRAPHY A, vol. 1100, iss. 1, pp. 116-125, 2005.
Z. Travnicek, M. Sipl, and I. Popa, “Palladium(II) complexes containing cytokinins derived from 6-benzylaminopurine,” JOURNAL OF COORDINATION CHEMISTRY, vol. 58, iss. 16, pp. 1513-1521, 2005.
Z. Travnicek, A. Klanicova, I. Popa, and J. Rolcik, “Synthetic, spectral, magnetic and in vitro cytotoxic activity studies of cobalt(II) complexes with cytokinin derivatives: X-ray structure of 6-(3-methoxybenzylamino)purinium chloride monohydrate,” JOURNAL OF INORGANIC BIOCHEMISTRY, vol. 99, iss. 3, pp. 776-786, 2005.

2004

Z. Travnicek, I. Popa, and K. Dolezal, “6-(4-methoxybenzylamino)purin-3-ium chloride,” ACTA CRYSTALLOGRAPHICA SECTION C-CRYSTAL STRUCTURE COMMUNICATIONS, vol. 60, iss. Part 9, p. O662-O664, 2004.

2002

Z. Travnicek, M. Malon, I. Popa, K. Dolezal, and M. Strnad, “Preparation and cytotoxic activity of nickel(II) complexes with 6-benzylaminopurine derivatives,” TRANSITION METAL CHEMISTRY, vol. 27, iss. 8, pp. 918-923, 2002.